Suchen und Finden

Titel

Autor

Inhaltsverzeichnis

Nur ebooks mit Firmenlizenz anzeigen:

 

Textbook of Small Animal Emergency Medicine

Textbook of Small Animal Emergency Medicine

Kenneth J. Drobatz, Kate Hopper, Elizabeth A. Rozanski, Deborah C. Silverstein

 

Verlag Wiley-Blackwell, 2018

ISBN 9781119028949 , 1536 Seiten

Format PDF, OL

Kopierschutz DRM

Geräte

218,99 EUR

Für Firmen: Nutzung über Internet und Intranet (ab 2 Exemplaren) freigegeben

Derzeit können über den Shop maximal 500 Exemplare bestellt werden. Benötigen Sie mehr Exemplare, nehmen Sie bitte Kontakt mit uns auf.

Mehr zum Inhalt

Textbook of Small Animal Emergency Medicine


 

Textbook of Small Animal Emergency Medicine

3

Contents

7

Contributors

15

Dedication

30

Preface

31

About the Companion Website

32

Section 1 Emergency Medicine Overview

33

1 Goals in Veterinary Emergency Medicine

35

The 40-Year Evolution of Goals in Veterinary Emergency Medicine

35

The Patient

35

The Client and the Team

35

Principles of Primary Survey, Resuscitation, Secondary Survey and Definitive or Refined Diagnostics and Treatment of Veterinary Emergency Patients

36

References

37

2 Triage

38

Introduction

38

Telephone Triage

38

First Aid and Transport

38

Waiting Room Triage

39

Investigation and Stabilization of the Patient

40

History

40

Emergency Physical Examination

41

Emergency Stabilization

42

References

42

Section 2 Common Conditions in Emergency Medicine

43

3 Neurological Disorders

45

Initial Management of the Acute Neurological Patient

45

Neuroanatomic Localization

45

Initial Assessment

45

Consciousness

45

Posture and Body Position

46

Abnormal Movements

46

Ambulation and Gait

46

Cranial Nerves

47

Neurolocalization

47

Approach to Differential Diagnoses

47

References

49

4 Respiratory Distress

50

Introduction

50

Does Oxygen Help?

50

Signalment

51

Any Relevant Past Medical History? What Has Happened Today?

51

Is There Hyperthermia or Hypothermia?

51

Is There Loud Breathing?

51

Is There Any Cough or Wheeze?

52

Are There Extra Lung Sounds?

52

What Does Point-of-Care Ultrasound Show You?

53

What Should I Tell the Owner?

53

References

53

5 Ventricular Ectopy

54

Introduction

54

Presentation

54

Diagnosis

54

Causes

54

Non-Cardiac Causes

54

Cardiac Causes

55

Treatment

55

Class I Antiarrhythmics

55

Class II Antiarrhythmics

56

Class III Antiarrhythmics

56

Other Antiarrhythmics

57

Defibrillation

57

6 Acute Abdomen

58

History and Physical Examination

58

Clinical Pathology

58

Abdominal Imaging

58

Collection of Peritoneal Effusion

59

Analysis of Peritoneal Effusion

60

Abdominal Surgery

61

Nutritional Support

61

Conclusion

61

References

61

7 The Collapsed Patient

63

Introduction

63

Pathophysiology of Syncope

63

Causes of Syncope

64

Cardiac Syncope

64

Reflex-Mediated Syncope

65

Collapse or Syncope-Like Conditions

66

Patient Evaluation and Risk Stratification

67

Blood Pressure

67

ECG

67

Long-Term Monitoring

67

Bloodwork

67

Treatment

68

References

69

8 Global Approach to the Trauma Patient

71

Introduction

71

Pathophysiology

71

Triage Evaluation and Intervention

72

Further Evaluation

73

Diagnostic Imaging

74

Conclusion

75

References

75

9 Reproductive Emergencies

76

Introduction

76

Female Reproductive Emergencies

76

Vaginal Discharge

76

Swollen Vulva or Mass Lesion

77

Reproductive Emergencies of the Pregnant Patient

77

Reproductive Emergencies of the Periparturient Patient

77

Male Reproductive Emergencies

78

Paraphimosis and Priapism

78

Prostate Disorders

78

Testicular Torsion

78

References

79

10 Anemia

80

Introduction

80

Etiology

80

Consequences of Anemia

80

Clinical Signs

82

Diagnosis

82

History

82

Physical Examination

82

Laboratory Assessment

82

Diagnostic Approach

84

Decreased Erythropoiesis

84

Hemorrhagic Anemia

85

Hemolytic Anemia

85

References

85

11 Jaundice

87

Definition

87

Physiology

87

Pathophysiology

87

Evaluation of the Icteric Patient

88

Physical Examination

88

Diagnostic Evaluation

90

Treatment

91

References

91

12 Ophthalmic Emergencies

92

Proptosis

92

Eyelid Lacerations

92

Corneal Lacerations

92

Deep Corneal Ulcers

94

Primary Glaucoma

95

Acute Anterior Uveitis

95

Anterior Lens Luxation

95

Acute Blindness

96

References

97

13 Vomiting, Regurgitation, and Diarrhea

98

Differentiation Between Vomiting and Regurgitation

98

Vomiting

98

Physiology of Vomiting

98

Differential Diagnoses

98

Clinical Approach

98

General Treatment Guidelines

99

Regurgitation

99

Differential Diagnoses

99

Clinical Approach

100

General Treatment Guidelines

100

Prognosis

101

Diarrhea

101

Gastrointestinal Causes

101

Extragastrointestinal Causes

101

Clinical Approach

101

Treatment

102

References

102

14 Dysuria

104

Introduction

104

Alteration in Volume or Frequency of Urination

104

Dysuria

104

Stranguria

104

Pollakiuria

104

Decreased Size of Urine Stream

105

Reflex Dyssynergia

105

Urinary Obstruction

105

Periuria

105

Incontinence

105

Polyuria/Polydipsia

105

Alteration in Urine Consistency

105

Discolored Urine

105

Malodorous Urine

105

Crystalluria or Small Uroliths in Urine

105

Other Clinical Findings That May Be Associated With Lower Urinary Tract Disease

106

Abdominal Fluid

106

Excessive Licking of Prepuce or Vulva

106

Blood Dripping from Prepuce or Vulva

106

Prostatomegaly

106

Purulent Discharge from Prepuce or Vulva

106

Painful Rectal Examination

106

Painful Defecation

106

Painful or Abnormal Gait of Rear Limbs

106

Fever

106

Physical Examination Findings in Patients with Lower Urinary Tract Signs

106

Additional Analytical Procedures in Patients with Dysuria

107

Management of Patients with Dysuria

107

References

107

15 Dermatological and Ear Disease

108

Dermatological Emergencies

108

Pyotraumatic Dermatitis

108

Pyoderma

109

Otitis Externa

112

Ectoparasites

116

Atopy

118

Conclusion

120

References

120

16 Toxin Exposure

124

Introduction

124

References

128

17 Epistaxis

129

Introduction

129

Pathophysiology

130

Further Laboratory Evaluation

130

Nasal Imaging

130

Nasal Biopsy

130

Emergency Management

131

Conclusion

131

References

132

18 Fever

133

Physiology of Normal Thermoregulation

133

What is Fever?

133

Is Fever Helpful or Harmful?

133

How to Differentiate Fever from Hyperthermia

134

History

134

Clinical Signs

134

Primary Differentials for Cause of Fever

134

Early Diagnostics to Consider for Febrile Patients

135

Treatments to Consider

136

References

137

Section 3 Emergency Conditions by System

139

A. Neurological Disorders

141

19 Traumatic Brain Injury

143

Introduction

143

Pathophysiology

143

Physical Examination

144

Systemic Assessment

144

Neurological Assessment

144

Diagnostic Imaging

144

Treatment

145

Initial Stabilization

145

Treatment Strategies Specific for TBI

145

Prognosis

147

References

147

20 Altered Mentation

150

Introduction

150

Initial Assessment (see Chapter 2)

150

Neuroanatomy

150

Neurological Examination

150

Mental Status and Neurological States of Consciousness

150

Neuro-ophthalmological Signs

151

Postural Response

151

Respiratory Patterns

152

Differential Diagnoses and Diagnostic Approach

152

Diagnostic Approach

152

Laboratory Testing

152

Advanced Neurological Testing

152

Treatment and Monitoring

153

Conclusion

154

References

154

21 Seizures

156

Introduction

156

History

156

Initial Patient Assessment (see Chapter 2)

156

Neurological Examination

157

Differential Diagnoses

157

Quick Assessment Tests

158

Extended Laboratory Tests and Diagnostic Images

158

Emergency Management

158

Benzodiazepines

159

Phenobarbital

159

Levetiracetam

159

Propofol

159

Ketamine

160

Dexmedetomidine

160

Acepromazine

160

Intracranial Pressure

160

Long-term Management of Seizures

161

References

162

22 Intracranial Disease

163

Clinical Signs

163

Diagnostic Tests

163

Differential Diagnoses and Prognosis

164

Neoplasia

164

Immune Mediated

164

Infectious

165

Vascular

165

Metabolic

166

Congenital Malformation

166

Trauma

167

References

167

23 Vestibular Disease

169

Introduction

169

Clinical Signs (Table 23.1)

169

Peripheral Vestibular Disease

169

Central Vestibular Disease

170

Paradoxical Vestibular Disease

170

Bilateral Peripheral Vestibular Disease

171

Common Causes of Vestibular Disease (Table 23.2)

171

Peripheral Vestibular Disease

171

Central Vestibular Disease

172

Diagnostics

174

References

175

24 Spinal Trauma

178

Causes

178

Pathophysiology

178

Initial Approach

178

Neurological Assessment

180

Localizing spinal cord lesions

180

Severity and Prognostication

180

Diagnosis

181

Radiography

181

Myelography

181

Computed Tomography

181

Magnetic Resonance Imaging

182

Treatment of Spinal Cord Injury

182

Management of Secondary Spinal Cord Injury

182

Management of Primary Spinal Cord Injury

182

Nursing, Rehabilitation, and Ongoing Care

183

References

183

25 Intervertebral Disk Disease

186

Introduction

186

Applied Anatomy

186

Pathogenesis

186

Disk Protrusion and Extrusion

187

Clinical Signs

187

Diagnostics

189

Treatment

189

Medical Management

189

Surgical Management of IVDH

190

References

191

26 Diskospondylitis

193

Introduction

193

Pathophysiology

193

Causative Agents

193

Signalment

194

Clinical Signs

194

Diagnosis

194

Radiography

194

Cross-Sectional Imaging

195

Laboratory Tests

195

Treatment

196

Prognosis

196

Complications

197

References

197

27 Lower Motor Neuron Disease

198

Introduction

198

Clinical Signs

198

Diagnosis and Initial Approach

198

Causes of Generalized Lower Motor Neuron Paresis

202

Acute Polyradiculoneuritis

202

Tick Paralysis

203

Botulism

204

Fulminant Myasthenia Gravis

204

Other Causes

205

References

206

B. Respiratory Disease

209

28 Brachycephalic Syndrome

211

Introduction

211

Systemic Consequences of the Brachycephalic Obstructive Airway Syndrome

211

Acute Upper Airway Obstruction: Current Concepts

212

Treatment of Brachycephalic Syndrome

215

Future Directions

216

References

216

29 Feline Upper Respiratory Complex

218

Introduction

218

Causes/Infectious Agents

218

Feline Herpesvirus-1

218

Feline Calicivirus

218

Clinical Presentation

219

Feline Herpesvirus-1

219

Feline Calicivirus

219

Risk Factors

220

Diagnosis

220

Treatment (Table 29.2)

220

Supportive Treatment

220

Antibiotics

220

Antivirals

222

Prevention

222

Prognosis

222

References

223

30 Laryngeal Paralysis

225

Introduction

225

Clinical Signs

225

Emergency Treatment

225

Emergency Diagnostic Tests

226

Long-Term Management

227

Prognosis

227

References

227

31 Tracheobronchial Injury and Collapse

228

Anatomy and Physiology of the Trachea

228

Emergency Management

228

Tracheobronchial Injury

229

Clinical Signs and Physical Examination Findings

229

Diagnostic Testing

230

Treatment of Tracheobronchial Injuries

231

Tracheal and Bronchial Collapse

232

Clinical Signs and Physical Examination Findings

232

Diagnostic Testing

233

Treatment of Tracheobronchial Collapse

233

References

235

32 Acute Airway Obstruction

238

Emergency Examination

238

Emergency Stabilization

238

Diagnostics

239

Complications of Upper Airway Obstruction

240

Diseases Causing Upper Airway Obstruction (Table 32.1)

240

Diseases of the Nasal Passage and Nasopharynx

240

Diseases of the Larynx and Pharynx

241

Diseases of the Trachea and Bronchi

242

References

243

33 Exacerbations of Chronic Bronchitis

247

Introduction

247

Disease Syndrome

247

Diagnosis

247

Treatment (Table 33.1)

248

Causes of Exacerbation

248

Airway Collapse

248

Mucus Obstruction

248

Bronchiectasis

249

Infection

249

Pulmonary Hypertension

250

Obesity Hypoventilation Syndrome

250

Emergency Management of Disease Exacerbations

250

References

251

34 Feline Lower Airway Disease

252

Introduction

252

Patient History

252

Initial Assessment

252

Emergency Treatment

252

Differential Diagnosis

253

Feline Asthma

253

Chronic Bronchitis

254

Lungworm Disease

254

Heartworm-Associated Respiratory Disease

254

References

255

35 Puppy Pneumonia

257

Introduction

257

Clinical Approach

258

Diagnostic Testing

258

Treatment Options

259

Prognosis

260

Brachycephalic Dogs

260

References

260

36 Coughing and Hemoptysis

261

Introduction

261

Physiology

261

Differential Diagnosis

262

Hemoptysis

262

Infectious Tracheobronchitis

262

Foreign Body

262

Anatomical Disruption

263

Neoplasia

263

Diagnostic Approach

263

Treatment

264

References

264

37 Bronchopneumonia

266

Introduction

266

Types of Pneumonia

266

Bacterial Pneumonia

266

Aspiration Pneumonia

267

Viral Pneumonia

267

Fungal Pneumonia

267

Protozoal Pneumonia

267

Parasitic Pneumonia

267

Physical Examination Findings

267

Diagnostics

268

Diagnostic Imaging

268

Clinicopathological Evaluation

269

Lung Function and Hemodynamic Monitoring

269

Airway Sampling for Cytology and Microbiology

269

Treatment

270

Antimicrobials

270

Supportive Care

270

Long-Term Therapy

270

Prognosis

271

References

272

38 Cardiogenic Pulmonary Edema

274

Introduction

274

Diuretics

274

Vasodilators

275

Positive Inotropes

277

Vasopressors

278

Sedatives

278

Oxygen Therapy

278

Other Therapies

278

References

278

39 Neurogenic Pulmonary Edema

279

Introduction

279

Pathogenesis

279

Blast Theory [1]

279

Direct Pulmonary Vascular Effect

280

Summary of Pathogenesis

280

Clinical Characteristics of Neurogenic Pulmonary Edema

280

Diagnosis

281

Initial Approach and Management

282

Monitoring the Effectiveness of Therapy

283

Prognosis

284

References

284

40 Submersion Injury

285

Introduction

285

Definitions

285

Precipitating Factors

285

Pathophysiology

285

Complications of Submersion Injury

286

Diagnosis and Treatment

287

Outcome

290

References

290

41 Pulmonary Hemorrhage

292

Etiology and Pathogenesis

292

Etiology

292

Pathogenesis

293

Patient Evaluation

293

History and Physical Examination Findings

293

Diagnosis

294

Radiography

294

Lung Ultrasound (see Chapter 182)

294

Computed Tomography

294

Echocardiography

294

Transtracheal Wash, Bronchoalveolar Lavage, Cytopathology, Histopathology, and Culture

294

Hematology: Complete Blood Count, Serum Chemistry, Coagulation Testing, and Other Laboratory Tests

295

Advanced Pulmonary Testing

295

Treatment

296

Outcome

296

References

296

42 Pulmonary Thromboembolism

298

Introduction

298

Risk Factors

298

Pathophysiology

298

Clinical Signs

299

Diagnosis

299

Coagulation Testing

299

Thoracic Radiographs

299

Arterial Blood Gas

300

Echocardiography

300

CT Pulmonary Angiography

301

Biomarkers

302

Management

302

Mechanical Ventilation

302

Anticoagulants and Thrombolytics

302

References

303

43 Primary and Metastatic Pulmonary Neoplasia

305

Introduction

305

Diagnostic Tests

306

Imaging

306

Laboratory Tests

306

Treatment and Prognosis

307

Pulmonary Carcinoma

307

Metastatic Pulmonary Nodules

307

Mesothelioma and Carcinomatosis

307

Conclusion

308

References

308

44 Pneumothorax

310

Anatomy

310

Pathogenesis

310

Traumatic Pneumothorax

310

Iatrogenic Pneumothorax

310

Spontaneous Pneumothorax

310

Clinical Consequences of Pneumothorax

312

Physical Examination

312

Diagnosis

312

Thoracocentesis

312

Ultrasound (see Chapter 182)

312

Radiography

313

Computed Tomography

313

Determining the Underlying Cause of Pneumothorax

313

Treatment

313

Thoracostomy Tubes

313

Continuous Suction

314

Pleurodesis and Blood Patching

314

Lung Lobectomy

314

Medical Therapy for Secondary Spontaneous Pneumothorax

314

References

315

45 Pleural Effusion

317

Introduction

317

Clinical Signs

317

Initial Treatment

317

Types of Effusions

318

Transudates

318

Hemorrhagic Effusion

319

Neoplastic Effusion

319

Exudates

319

Chylous Effusions

320

Conclusion

321

References

321

46 Pyothorax

323

Introduction

323

Etiology

323

Microbiology

323

Signalment

324

Clinical Signs and Physical Examination Findings

324

Diagnosis

324

Clinicopathological Findings

324

Thoracic Imaging

324

Treatment

325

Antimicrobial Therapy

326

Thoracic Drainage

326

Thoracic Lavage

326

Surgical Management

327

Prognosis

327

References

327

47 Diaphragmatic Hernia

330

Anatomy

330

Types of Hernias

330

Congenital

330

Acquired

330

Clinical Signs

331

Congenital

331

Acquired

331

Diagnosis

331

Physical Examination

331

Diagnostic Imaging

331

Laboratory Assessment

332

Treatment

332

Surgical Intervention

332

Postoperative Care

333

Complications and Prognosis

333

References

333

48 Penetrating Thoracic Trauma

336

Introduction

336

Etiology

336

Physical Examination and Diagnostics

336

Treatment

337

Fluid and Blood Products

337

Respiratory Stabilization

337

Pain Management

338

Antibiotics

338

Surgical Indications and Procedures

338

Anesthetic Considerations

339

Surgical Management

339

Prognosis

339

References

339

49 Blunt Thoracic Trauma

341

Introduction

341

Etiology

341

Pathophysiology

341

Physical Examination and Diagnostics

343

Treatment

343

Surgical Indications

344

Prognosis

345

References

345

50 Look-Alike Causes of Respiratory Distress

348

Introduction

348

Look-Alike Causes of Respiratory Distress

348

Decreased Oxygen Delivery (DO2)

348

Acid–Base Disorders

349

Brain Disease

349

Behavioral and Thermal Receptor Causes

349

Drugs

349

References

350

C. Cardiovascular Disease

351

51 Mechanisms of Heart Failure

353

What is Heart Failure?

353

Neuroendocrine Systems in Heart Failure

353

Maladaptive Responses in Heart Failure

354

Global Cardiac Function in Heart Failure

354

Treatment

355

Conclusion

355

References

355

52 Congenital Cardiovascular Disease

357

Introduction

357

Diagnosis

357

Cyanosis

357

Congestive Heart Failure

359

Syncope/Collapse

359

Conclusion

360

References

360

53 Arrhythmias

361

Introduction

361

Tachycardias

362

Supraventricular Tachycardia

362

Ventricular Tachycardia

362

Treating Supraventricular Tachycardias

363

Treating Ventricular Tachycardias

363

Bradycardias

365

References

367

54 Pericardial Effusion

368

Etiology

368

Pathophysiology

369

Clinical Presentation

369

Diagnostic Testing

369

Pericardiocentesis

370

Management and Prognosis

370

References

371

55 Dilated Cardiomyopathy

373

Introduction

373

Etiology

373

Signalment, Prevalence, and Incidence

373

Stages

373

Diagnosis

374

Presentation, Clinical Signs, and Physical Examination Findings

374

Diagnostic Tests

374

Electrocardiographic Findings

374

Focused Ultrasound Findings

375

Thoracic Radiographic Findings

375

Echocardiographic Findings

375

NT-proBNP Testing

376

Other Ancillary Tests

376

Treatment

376

Prognosis

379

References

379

Further Reading

380

56 Feline Hypertrophic Cardiomyopathy

381

Introduction and Definitions

381

Pathology and Pathophysiology

381

Diastolic Dysfunction and Congestive Heart Failure

381

Arterial Thromboembolism

381

Presentation and Clinical Signs

381

Initial Stabilization

382

Congestive Heart Failure

382

Arterial Thromboembolism

382

Diagnostic Tests

383

Thoracic Radiography

383

Echocardiography

383

Biomarkers

383

Other Diagnostics

384

Chronic Therapy

385

Prognosis

385

References

385

57 Valvular Heart Disease

387

Introduction

387

Myxomatous Valvular Degeneration

387

Diagnosis (Table 57.1)

387

Signalment and Historical Findings

387

Physical Examination

388

Echocardiography

388

Focused Assessment by Sonographic Technique

389

Radiography

389

Biomarkers

389

Pathophysiology of Congestive Heart Failure (see Chapter 51)

389

Left-Sided Congestive Heart Failure

389

Right-Sided Congestive Heart Failure

390

Pulmonary Hypertension Due to Left-Sided Heart Disease

390

Left Atrial Tears

391

Treatment (Table 57.2)

391

Prognosis

392

References

392

58 Heartworm Disease

394

Introduction

394

Pathophysiology

394

Clinical Presentation and Physical Examination

395

Diagnosis (Table 58.1)

396

Serology

396

Radiography

397

Echocardiography

398

Clinical Pathology

399

Treatment of Specific Syndromes

399

Eosinophilic Pneumonitis

399

Heartworm Disease in Cats and Heartworm-Associated Respiratory Disease

399

Pulmonary Thromboembolism

399

Right-Sided Congestive Heart Failure

399

Caval Syndrome

400

Complications After Microfilaricidal or Adulticidal Therapy

400

References

401

59 Pulmonary Hypertension

404

Pathophysiology

404

Defining Pulmonary Hypertension

404

Pulmonary Hypertension at the Cellular Level

404

Classification of Pulmonary Hypertension

404

Common Veterinary Causes of Pulmonary Hypertension

405

Cor Pulmonale

405

Definition and Description

405

Clinical Presentation

405

Patient Signalment and History

405

Recognizing Pulmonary Hypertension

406

Patient History

406

Diagnosis

406

Emergent Diagnostics

406

Completing the Diagnostic Plan

406

Treatment

407

Therapy in the Acute Setting

407

Long-Term Therapy Options

410

Follow-Up and Prognosis

410

References

410

60 Bradyarrhythmias and Pacemakers

412

Introduction and Definitions

412

Physiological Bradyarrhythmias

412

Iatrogenic Bradyarrhythmias

412

Pathological Bradyarrhythmias

412

Atrioventricular Block (AVB)

413

Sick Sinus Syndrome

414

Persistent Atrial Standstill

414

Clinical Management of Dogs and Cats with Bradyarrhythmias

414

Initial Stabilization

414

Indications for Permanent Pacing

416

Work-Up of Dogs and Cats with Bradyarrhythmias

416

References

416

61 Myocarditis

417

Introduction

417

Parvovirus

417

Chagas’ Disease

417

Lyme Disease

417

Bartonella

418

Toxoplasmosis

418

Traumatic Myocarditis

418

Diagnosis

418

Treatment

419

Further Reading

419

62 Thromboembolic Disease

420

Introduction

420

Pathophysiology of Thrombosis

420

Diagnosis of Thrombosis

420

General Aspects of the Treatment and Prevention of Thrombosis

421

Feline Aortic Thromboembolism

422

Canine Aortic Thrombosis

423

Portal Vein Thrombosis

423

Splenic Thrombosis

424

Mesenteric Thrombosis

424

Caval Thrombosis

424

Cerebral Infarction

425

Myocardial Thrombosis

425

References

426

63 Systemic Arterial Hypertension

429

Introduction

429

Pathophysiology of Systemic Hypertension

429

Target Organ Damage Caused by Systemic Hypertension

430

Neurological Target Organ Damage

430

Ocular Target Organ Damage

430

Cardiovascular Target Organ Damage

430

Renal Target Organ Damage

430

Conditions Associated with Systemic Hypertension

431

Clinical Recognition of Systemic Hypertension

431

Clinical Presentation

431

Blood Pressure Measurement

431

Treatment of the Patient with Systemic Hypertension

432

Prognosis and Long-Term Management

432

References

434

D. Hematological and Oncological Disorders

437

64 Leukocytosis and Leukopenia

439

Introduction

439

Leukocytosis

439

Neutrophilia

439

Neoplasia

440

Other Cell Lines

441

Treatment

441

Leukopenia

441

Neutropenia

441

Lymphopenia

442

Treatment

441

References

443

65 Non-Regenerative Anemia

445

Introduction

445

Erythropoiesis

445

Pathophysiological Response to Non-Regenerative Anemia

445

Diagnostic Approach

445

Bone Marrow Sampling and Analysis

447

Primary Bone Marrow Disorders

447

Secondary Extramarrow Disorders

448

Therapies for Non-Regenerative Anemia

448

References

449

66 Hemolytic Anemia

451

Introduction

451

History and Physical Examination

451

Laboratory Assessment

451

Differential Diagnoses for Hemolytic Anemia

451

Immune-Mediated Hemolytic Anemia (IMHA)

451

Alloimmune Hemolytic Anemia

453

Oxidative Hemolysis

453

Zinc and Copper Toxicity

453

Erythroparasites

454

Inherited Erythrocyte Defects

455

Microangiopathic Hemolysis

455

Hypophosphatemia

455

References

456

67 Thrombocytopenia

459

Platelets

459

Thrombocytopenia Etiology

459

Clinical Signs

460

Diagnosis

460

Treatment

460

References

461

68 Fibrinolysis and Antifibrinolytics

462

Introduction

462

Physiology of Fibrinolysis

462

Disorders of Fibrinolysis

463

Hyperfibrinolysis

463

Hypofibrinolysis

464

Evaluation of the Fibrinolytic System

464

D-dimers

464

Euglobulin Clot Lysis Time (ECLT)

464

tPA Assays

465

Plasminogen

465

Plasminogen Activator Inhibitor-1

465

Thrombin-Activatable Fibrinolysis Inhibitor

465

Alpha-2-Antiplasmin

465

Viscoelastic Testing

465

Management of Hyperfibrinolysis

466

Therapeutic Fibrinolysis

467

References

468

69 Congenital Coagulopathy

472

Introduction

472

Dogs

472

Cats

472

Animals Presenting with Unexplained Hemorrhage

472

Animals with Known Inherited Defects

473

Von Willebrand’s Disease

474

Hemophilia A

474

Hemophilia B

474

Conclusion

474

References

474

70 Acquired Coagulopathy

476

General Approach

476

Anticoagulant-Associated Coagulopathy

476

Heparins

476

Antiplatelet Drugs

477

Novel Oral Anticoagulants

477

General Management

478

Specific Management

478

Disseminated Intravascular Coagulation

480

Pathogenesis

480

Diagnosis

481

Treatment

481

Acute Traumatic Coagulopathy

482

Hepatobiliary Disorders

482

Pathophysiology

482

Diagnosis and Treatment

483

Diagnosis and Treatment

483

Neoplasia

483

References

484

71 Antithrombotics in the Emergency Room

487

Introduction

487

References

490

72 Sick Oncology Patients in the Emergency Room

491

Introduction

491

Febrile Neutropenia and Sepsis

491

Hypercalcemia

492

Acute Tumor Lysis Syndrome

494

Thromboembolism and Hemostatic Abnormalities

494

Hemangiosarcoma

495

Conclusion

496

References

496

73 Paraneoplastic Syndromes

499

Hypercalcemia of Malignancy

499

Hypoglycemia

500

Polycythemia

500

Anemia

501

Thrombocytopenia

501

Coagulopathies/Disseminated Intravascular Coagulation

501

Hypertrophic Osteopathy

502

Fever

502

Miscellaneous

502

References

502

E. Esophageal and Abdominal Disease

505

74 Vomiting and Regurgitation

507

Vomiting

507

Physiology

507

Sequelae of Vomiting

507

Diagnostics

507

Therapy

509

Regurgitation

510

Physiology

510

Sequelae

510

Diagnostics

510

Treatment

511

References

511

75 Esophageal Foreign Bodies

513

Introduction

513

Presentation

513

Diagnosis

513

Treatment

514

Outcome

515

Esophagitis

515

Esophageal Perforation

515

Esophageal Stricture

515

References

516

76 Diarrhea

517

Introduction

517

Diagnostic Approach

517

Causes of Diarrhea (Table 76.1)

518

Primary Gastrointestinal Disease

518

Extraintestinal Diseases

519

Treatment

520

Supportive Treatment

520

Fluid Therapy

520

Antiparasitic and Antimicrobial Therapy

520

Dietary Therapy

520

Other Therapies

520

References

521

77 Hematemesis and Gastrointestinal Hemorrhage

522

Introduction

522

Etiology and Pathophysiology

523

Clinical Signs and Physical Examination

524

Laboratory Evaluation

524

Diagnostic Imaging

525

Endoscopy

525

Exploratory Laparotomy

525

Treatment

525

Prognosis

526

References

526

78 Parvovirus Enteritis

528

Pathogenesis

528

Clinical Signs

528

Diagnostic Tests

529

Treatment and Monitoring

529

Prognosis

531

Husbandry Considerations

531

References

531

79 Hemorrhagic Gastroenteritis

533

Introduction

533

Investigation into the Underlying Etiology

533

Clinical Recognition and Diagnosis

534

Emergency Stabilization and Treatment

535

Prognosis

536

References

536

80 Protein-Losing Enteropathy

538

Introduction

538

Pathophysiology

538

Clinical Presentations and Laboratory Data

539

Treatment

539

Hypoalbuminemia

539

Hypercoagulability

540

Nutritional and Fluid Support

540

Calcium Homeostasis

540

Immunosuppressive Therapy

540

Prognosis and Follow-Up Care

540

Protein-Losing Enteropathy in Feline Patients

541

References

541

81 Gastrointestinal Obstruction

543

Introduction

543

Etiology

543

Pathophysiology

543

Clinical Signs and Physical Exam

544

Diagnostics

545

Radiography

545

Specific Conditions

547

Non-Obstructive Foreign Body

547

Linear Foreign Bodies

548

Intussusception

548

Postoperative Complications and Care

548

Overview

549

References

549

82 Gastric Dilation-Volvulus

552

Introduction

552

Diagnosis and Treatment

552

Surgical Management

554

Outcome

554

References

554

83 Mesenteric Torsion

556

Introduction

556

Pathophysiology

556

History and Clinical Signs

557

Diagnostics

557

Treatment

558

References

559

84 Hemoperitoneum

560

Introduction

560

History and Signalment

560

Clinical Signs and Physical Examination Findings

560

Initial Treatment and Stabilization

561

Diagnostics

562

Definitive Care and Prognosis

564

References

565

85 Splenic Disease

567

Splenic Disease in the Emergent Patient

567

Splenic Masses in Dogs

567

Splenic Torsion

569

Splenic Trauma

570

Splenic Infarction

570

Splenic Abscesses

570

Miscellaneous Conditions Causing Diffuse Splenomegaly in Dogs

570

Feline Splenic Disease

570

References

571

86 Pancreatitis

573

Introduction

573

Pathophysiology

573

History, Signalment, and Clinical Signs

573

Diagnosis

574

Diagnostic Imaging

575

Fluid Analysis

576

Biopsy and FNA

576

Scoring Disease and Assessing Severity

576

Treatment

576

Prognosis and Owner Communication

578

References

578

87 Peritonitis

582

Introduction

582

Etiology

583

Immune Response

583

Signalment and History

583

Physical Examination

583

Diagnostics

584

Treatment

585

Fluid Therapy

585

Antimicrobial Therapy

585

Pain Management

585

Antiemetics, Antacids, and Prokinetics

586

Nutrition

586

Prognosis

586

References

587

88 Postoperative Complications Presenting to the Emergency Service

588

Introduction

588

Surgical Site Complications

588

Associated Complications

591

Conclusion

591

References

591

89 Biliary Disease

593

Introduction

593

Overview of Anatomy and Physiology

593

Presenting Signs and Initial Physical Examination

594

Diagnostics

594

Stabilization

594

Cardiovascular System

594

Respiratory System

595

Neurological System

595

Acute Medical Therapy

595

Surgery

595

Prognosis

597

References

597

90 Acute Liver Failure

598

Introduction

598

Pathophysiology

598

Presenting Complaint and Clinical Signs

599

Cardiovascular Signs

600

Respiratory Signs

600

Neurological Signs

600

Renal Signs

600

Causes

600

Diagnostic Tests

603

Emergency Stabilization and Treatment

604

Prognosis

607

Conclusion

607

References

607

91 Feeding Tube Complications

610

Introduction

610

Complications Associated with Placement of Feeding Tubes

610

Complications Associated with Feeding Tube Use

611

Complications Encountered After Placement of Feeding Tubes

611

Conclusion

612

References

613

92 Anorectal Disease

614

Introduction

614

Anatomy

614

Perforation

614

Rectal Prolapse

616

Other Diseases

617

Anal Sac Diseases

617

Rectal Neoplasia

617

Perianal Fistulae

617

References

618

93 Constipation

619

Introduction

619

History

619

Physical Examination

620

Diagnostics

620

Treatment

621

Disimpaction of Feces

621

Maintenance Therapy

622

Prognosis

622

References

622

F. Urogenital Disorders

710

94 Acute Azotemia

712

Introduction

712

Prerenal Azotemia

713

Intrinsic Renal Azotemia

713

Postrenal Azotemia

713

Diagnosis of Acute Azotemia

714

Physical Examination and History

714

Initial Diagnostics

715

Treatment

715

References

716

95 Oliguria

718

Pathogenesis of Oligoanuria

718

Patient Assessment and Initial Diagnostics

718

Managing the Oligoanuric Patient

719

Converting Oligoanuria to Polyuria

720

Extracorporeal Renal Replacement Therapy

721

References

721

96 Urinary Tract Infections

723

Definition

723

Incidence and Pathogenesis

724

History and Physical Examination

725

Diagnosis

726

Therapy

728

Management of Particular Conditions

734

Subclinical Bacteriuria

734

Urinary Tract Infections Associated with Urinary Catheters

734

Acute Prostatitis

735

Acute Pyelonephritis

735

References

736

97 Urolithiasis

737

Introduction

737

Diagnosis of Uroliths

737

Management of Uroliths Associated with Urinary Obstruction

738

Management of Uroliths Unassociated with Urinary Obstruction

738

Medical Treatment

738

Minimally Invasive Techniques

740

Surgical Treatment

740

References

741

98 Feline Ureteral Obstruction: Diagnosis and Management

744

Introduction

744

Etiology

744

Treatment of Feline Ureteral Obstructions

745

Traditional Surgery

745

Interventional Options

746

Postoperative Management

749

Conclusion

750

References

750

99 Feline Lower Urinary Tract Obstruction

751

Pathogenesis of Obstruction

751

Predisposing Factors

751

Pathophysiology of Obstruction

751

History and Clinical Signs

752

Initial Stabilization

752

Urethral Catheterization

753

Diagnostic Evaluation

755

Postobstructive Care

755

Alternative Management Protocols

755

At-Home Care

756

Prognosis

756

References

756

100 Urethral Trauma

758

Incidence

758

Patient Evaluation

758

Diagnosis

758

Treatment

759

Conservative Management

759

Surgical Management

760

Complications

761

Stricture Management

761

Outcome

761

References

761

101 Lyme Nephritis

763

Introduction

763

Transmission, Prevalence, and an Experimental Model of Canine Lyme Disease

763

Presentation of Field Cases with Presumptive Lyme Nephritis [1–4,15]

764

Diagnostic Work-Up to Stage Disease and Rule Out Other Differentials [1–4,9,10]

764

Renal Biopsy

766

Treatment (Table 101.2)

766

Monitoring

767

Prevention, Tick Control and Lyme Vaccination

768

References

768

102 Chronic Kidney Disease

770

Introduction

770

Pathophysiology

770

Presentation

771

Diagnostics

771

Laboratory Tests

771

Imaging

771

Monitoring

771

Stabilization and Initial Therapy

771

Fluid Therapy

771

Management of Anemia

772

Hypertension (see Chapter 63)

772

Management of Gastrointestinal Signs

772

Dose Reduction

773

Prognosis and Long-Term Management

773

Conclusion

774

References

774

103 Uroabdomen

776

Etiology and Pathogenesis

776

Clinical Signs and Physical Examination Findings

777

Diagnosis and Laboratory Evaluation

777

Laboratory Findings

777

Imaging Findings

777

Emergent Stabilization

778

Treatment

779

Complications and Prognosis

779

References

780

104 Urethral Prolapse

782

Urethral Prolapse

782

Diagnosis

782

Treatment

782

References

783

105 Discolored Urine

784

Introduction

784

Examination of the Urine Specimen

784

Abnormal Urine Sediment Color

784

Hematuria

784

Other Cells or Particles

785

Abnormal Urine Supernatant Color

785

Endogenous Pigments

785

Exogenous Pigments

787

Multifactorial Urine Discoloration

787

Pigment-Induced Renal Injury

788

Conclusion

788

References

788

106 Urinary Diversion in the Emergency Room

790

Urinary Catheterization

790

Indications

790

Contraindications

790

Complications

790

Percutaneous Nephrostomy Tube

791

Indications

791

Complications

792

Percutaneous Antegrade Urethral Catheterization

792

Indications

792

Complications

792

Cystoscopy and Urethroscopy

793

Indications

793

Complications

793

Cystostomy Tubes

794

Indications

794

Complications

795

Peritoneal Drainage

795

Indications

795

Complications

795

References

795

G. Acid-base, Electrolyte and Endocrine Disorders

798

107 Acid–Base Disorders

800

Introduction

800

Sample Considerations

800

Acid–Base Regulation

800

Acid–Base Analysis

801

Evaluate pH

801

Determine the Primary Disorder

801

Compensation

801

Primary Versus Mixed Disorders

802

Acid–Base Disorders

802

Respiratory Alkalosis

802

Respiratory Acidosis

802

Metabolic Alkalosis

803

Metabolic Acidosis

803

Acid–Base and Prognosis

804

Case Example 1

804

Case Example 2

804

Case Example 3

805

References

805

108 Sodium and Water Balance

807

Introduction

807

Hyponatremia

808

Etiology

808

Clinical Signs

808

Diagnosis

808

Treatment

809

Hypernatremia

811

Etiology

811

Clinical Signs

812

Diagnosis

812

Treatment

812

Prognosis

813

References

813

109 Potassium Disorders

817

Introduction

817

Potassium Homeostasis

817

Hypokalemia

817

Definition and Etiology

817

Symptoms

818

Treatment

819

Hyperkalemia

819

Definition and Etiology

819

Symptoms

821

Treatment

822

References

823

110 Calcium, Magnesium, and Phosphorus Disorders

826

Introduction

826

Phosphorus Homeostasis

826

Hypophosphatemia

827

Hyperphosphatemia

829

Calcium Homeostasis

830

Hypocalcemia

830

Hypercalcemia

831

Magnesium Homeostasis

832

Hypomagnesemia

833

Hypermagnesemia

834

References

834

111 Hypoglycemia

836

Introduction

836

Pathophysiology

836

Clinical Signs

837

Causes of Hypoglycemia

837

Excess Secretion of Insulin or Insulin-Like Factors

837

Decreased Glucose Production

838

Excess Glucose Consumption

839

Drug-Associated Causes

839

Spurious

839

Diagnosis

839

Treatment of a Hypoglycemic Crisis

840

References

840

112 Hyperglycemia

843

Introduction

843

Stress Hyperglycemia

843

Diabetes Mellitus

844

Insulin Deficiency and Insulin Resistance

844

References

845

113 Complicated Diabetes Mellitus

846

Introduction

846

Pathogenesis

846

History and Physical Examination

846

Diagnostic Evaluation in the Emergency Room

847

Triage Panel

847

Measure Blood Glucose Concentration

847

Measure Ketones and Assess Degree of Acidemia

847

Quantify Degree of Hyperosmolality

847

Assess Electrolyte Abnormalities

847

Stabilization and Emergency Treatment

848

Restore Effective Circulating Volume (see Chapter 153)

848

Provide Ongoing Fluid Therapy

848

Treat Electrolyte Abnormalities

848

Initiate Insulin Therapy

849

Identify and Treat Concurrent Diseases

850

Post-crisis Therapy for Diabetes Mellitus

850

Outcome

850

References

851

114 Adrenal Gland Disorders

853

Introduction

853

Pheochromocytoma

853

Incidence

853

Pathophysiology

853

Clinical Signs and Physical Examination

853

Diagnostic Results

854

Treatment

854

Surgical Outcome and Prognostic Factors

854

Hyperaldosteronism

854

Incidence

855

Pathophysiology

855

Clinical Signs and Physical Examination

855

Diagnostic Results

855

Treatment and Prognosis

855

Hyperadrenocorticism

855

Pathophysiology

856

Clinical Signs and Physical Examination

856

Diagnostic Results

856

Treatment and Prognosis

856

References

857

115 Hypoadrenocorticism

859

Etiology and Pathogenesis

859

Anatomy and Pathophysiology

859

Mineralocorticoid Deficiency

860

Glucocorticoid Deficiency

860

Patient Evaluation

860

History and Physical Examination Findings

860

Feline Hypoadrenocorticism

862

Diagnosis

862

Emergency Cage-Side Tests and Imaging

862

Complete Blood Count (CBC)

862

Serum Chemistry Panel

862

Resting or Basal Serum Cortisol Levels

863

ACTH Stimulation Testing

863

Cortisol-to-Adrenocorticotropic Hormone Ratio

863

Primary Versus Secondary Hypoadrenocorticism

863

Treatment

864

Fluid Therapy

864

Hyperkalemia

864

Acidosis

865

Glucocorticoids

865

Chronic Management

865

Complications

866

Outcome

866

References

866

116 Thyroid Disorders

869

Introduction

869

Thyroid Physiology

869

Thyroid Testing

869

Hyperthyroidism

870

Hypothyroidism

870

Clinical Presentations

870

Hyperthyroidism

870

Hypertensive Retinopathy

871

Thyroid Storm

871

Iatrogenic Hyperthyroidism

871

Hypothyroidism

872

Myxedema Coma

872

References

872

117 Diabetes Insipidus

874

Introduction

874

Pathophysiology

874

Recognizing Diabetes Insipidus in the Emergency Patient

874

History

875

Physical Examination

875

Clinicopathological Abnormalities

876

Definitive Diagnosis

876

Treatment

876

Water Replacement

876

AVP Administration

877

Complications of Treatment – Cerebral Edema

877

Patient Discharge

877

Prognosis

877

References

877

H. Reproductive Disorders

880

118 Dystocia

882

Female Reproductive Anatomy and the Physiology of Parturition

882

Anatomy

882

Physiology of Parturition

882

Estimating Expected Date of Parturition

883

Stages of Parturition

883

Dystocia

883

Risk Factors

883

Classifying Dystocia

883

When is Examination of the Bitch or Queen Warranted?

884

Clinical Examination

884

Diagnostics

884

Indicators for Intervention

885

Medical Management of Dystocia

885

Surgical Management

885

Postoperative Care and Management

886

References

886

119 Eclampsia

888

Introduction

888

Etiopathogenesis

888

Diagnosis

888

Treatment (Box 119.1)

889

Prevention

890

References

890

120 Neonatal Resuscitation

892

Physical Examination

892

Respiratory Concerns

893

Cardiac Concerns

893

Hypothermia

893

Dehydration and Fluid Therapy

894

Hypoglycemia

894

Sepsis

895

When to Stop Resuscitation Efforts

895

References

895

121 Diseases of the Neonate

896

Introduction

896

Epizootiology

896

Physiology

896

Neonatal Disorders in the Immediate Postpartum Period

897

Disorders of Metabolism

897

Anasarca

897

Ciliary Dyskinesia

898

Hydrocephalus

898

Umbilical Herniation

898

Bowel Malformation: Agenesis or Duplication

899

Patent Urachus

899

Cleft Palate

899

Neonatal Isoerythrolysis (see Chapter 66)

900

Immunodeficiency

900

Neonatal Ophthalmia

901

Limb Deformities: Amelia, Hemimelia (Absence of a Limb or Distal Portion of a Limb), Pelvic Limb Hyperextension

901

Neonatal Disorders in the Later Postpartum Period

901

Orphans

901

Aspiration Pneumonia

902

Swimmer Puppies

902

Juvenile Cellulitis

902

Bacterial Overgrowth Syndrome-Associated Diarrhea

903

Urinary Ectopia

904

Hypoglycemia

904

Fading Puppy Syndrome: Neonatal Bacterial Septicemia and Herpes Infection (CHV-1)

905

Trauma

906

References

906

122 Metritis and Mastitis

908

Metritis

908

Clinical Signs

908

Diagnostics

908

Treatment

909

Mastitis

909

Clinical Signs

909

Diagnostics

909

Treatment

910

References

910

123 Pyometra

912

Signalment, Clinical Presentation, and Associated Disease

912

Diagnostics

912

Treatment

913

Stabilization

913

Antibiotic Therapy

913

Surgical Versus Medical Management

913

Surgical Management

913

Medical Management

914

References

917

124 Prostatic Disease

919

Introduction

919

Anatomy

919

Diagnostics

919

Prostatic Disorders

920

Benign Prostatic Hyperplasia and Cystic Benign Prostatic Hyperplasia

920

Squamous Metaplasia

920

Paraprostatic Cysts

921

Infectious Prostatitis

921

Prostatic Neoplasia

922

References

923

125 Uterine and Vaginal Prolapse

924

Uterine Prolapse

924

Etiopathogenesis

924

Diagnosis

924

Treatment

924

Vaginal Prolapse

925

True Vaginal Prolapse

925

Vaginal Fold Prolapse (Canine Only)

926

References

928

126 Penile, Preputial, and Testicular Disease

929

Priapism

929

Pathophysiology

929

Clinical Presentation

929

Diagnostics

929

Therapy

930

Paraphimosis

931

Pathophysiology

931

Clinical Presentation

931

Diagnostics

931

Therapy

931

Phimosis

932

Pathophysiology

932

Clinical Presentation

932

Diagnostics

932

Therapy

932

Persistent Penile Frenulum

932

Pathophysiology

932

Clinical Presentation

932

Diagnostics

932

Therapy

932

Balanoposthitis

932

Pathophysiology

932

Clinical Presentation

932

Diagnostics

932

Therapy

933

Urethral Prolapse (see Chapter 104)

933

Pathophysiology

933

Clinical Presentation

933

Diagnostics

933

Therapy

933

Penile Trauma

933

Pathophysiology

933

Clinical Presentation

933

Diagnostics

933

Therapy

933

Infectious Orchitis and Epididymitis

933

Pathophysiology

933

Clinical Presentation

933

Diagnostics

934

Therapy

934

Testicular Torsion

934

Pathophysiology

934

Clinical Presentation

934

Diagnostics

934

Therapy

934

Scrotal Dermatitis

934

Pathophysiology

934

Clinical Presentation

934

Diagnostics

934

Therapy

934

References

935

I. Common Toxins

936

127 Decontamination and Toxicological Analyses of the Poisoned Patient

938

Introduction

938

Gastrointestinal Decontamination

938

Emetic Agents

938

Gastric Lavage

940

Activated Charcoal

942

Multidose Activated Charcoal

944

Complications

944

Administration of Charcoal

944

Toxicological Analyses

944

Conclusion

946

References

946

128 Lipid “Rescue” Therapy

948

Introduction

948

Available Formulations

948

Historical Use in Human Medicine

948

Use in Veterinary Medicine

949

Mechanism of Action

949

Recommended Dosing

950

Potential Complications

950

References

951

129 Blood Purification Techniques for Intoxications

952

Introduction

952

Intermittent Hemodialysis

952

Prolonged Intermittent HD and Continuous Therapies

953

Hemoperfusion

953

Combination Hemodialysis/Hemoperfusion

953

Apheresis

954

Indications for the Use of Extracorporeal Therapies in Treatment of Poisoning

955

Medical Management for Intoxications

956

Conclusion

956

References

956

130 Rodenticide Toxicity

958

Introduction

958

Decontamination

958

Anticoagulant Rodenticides

958

Neurotoxic Rodenticides

960

Cholecalciferol Rodenticides

961

Phosphide Rodenticides

961

Aldicarb Rodenticide

962

References

962

131 Ethylene Glycol Intoxication

963

Introduction

963

Clinical Signs

963

Diagnostic Testing

964

Treatment

965

Hemodialysis

966

References

966

132 Acetaminophen Intoxication

968

Introduction

968

Pharmacokinetics and Toxicokinetics

968

Toxic Doses

969

Clinical Signs

969

Gross and Histological Lesions

969

Diagnosis

969

Treatment

970

N-Acetylcysteine

970

Ascorbic Acid

970

Silymarin

971

Histamine Receptor Antagonists

971

S-Adenosyl Methionine

971

Methylene Blue

971

Prognosis

971

References

971

133 Non-Steroidal Anti-Inflammatory Drug Intoxications

973

Mechanism of Action

973

Pharmacokinetics

974

Adverse Effects

974

Gastrointestinal Toxicity

974

Renal Injury

974

Hepatic Injury

974

Coagulation and Hematological Issues

974

Neurological Complications

976

Treatment of NSAID Intoxication

976

References

977

134 Grape, Raisin, and Lily Ingestion

979

Grape, Raisin, and Currant Nephrotoxicity Pathogenesis

979

Lily Nephrotoxicity Pathogenesis

979

Physical Examination

980

Initial Diagnostics

980

Management of Non-Azotemic Animals Shortly After Exposure

980

Managing Patients with Established Acute Kidney Injury

981

Prognosis

981

References

981

135 Recreational Drug Intoxications

983

Cocaine

983

Mechanism and Toxicokinetics

983

Clinical Signs

983

Differential Diagnoses

983

Diagnostics

983

Treatment

983

Prognosis

984

Methamphetamine

984

Mechanism and Toxicokinetics

984

Clinical Signs

984

Diagnostics and Treatment

984

Differential Diagnoses

984

Prognosis

984

Marijuana

985

Mechanism and Toxicokinetics

985

Clinical Signs

985

Differential Diagnoses

985

Diagnostics

986

Treatment

986

Prognosis

986

Conclusion

986

References

987

136 Household Toxins

988

Decontamination

988

Common Household Toxin Exposures

988

Foods

988

Outdoor Products

989

Cleaning Products

990

Foreign Objects

990

Conclusion

991

References

991

J. Skin and Soft Tissue Disease

992

137 Life-Threatening Dermatological Emergencies

994

Dermatological Emergencies

994

Methicillin-Resistant Staphylococcal Infections (MRSIs)

994

Burns

995

Frostbite

997

Drug Eruption

998

Vasculitis

1000

Erythema Multiforme

1002

Toxic Epidermal Necrolysis and Stevens–Johnson Syndrome

1004

References

1006

138 Severe Soft Tissue Infections

1009

Introduction

1009

Etiology

1009

Pathophysiology

1009

Clinical Features (Table 138.1)

1010

Diagnosis (see Table 138.1)

1010

Treatment (see Table 138.1)

1011

Prognosis

1012

References

1013

K. Environmental Emergencies

1014

139 Smoke Inhalation Toxicity

1016

Introduction

1016

Pathophysiology of Smoke Inhalation

1016

Carbon Monoxide and Cyanide Exposure

1017

Physical Examination Findings

1018

Diagnostics

1018

Treatment

1019

Prognosis

1019

References

1020

140 Porcupine Quilling

1022

Introduction

1022

Prehospital Care

1022

Quill Removal

1022

Discharge Instructions

1023

Complicated Quillings

1023

Conclusion

1024

References

1024

141 Crotalinae Snake Envenomation

1025

Introduction

1025

Crotalinae Envenomation

1025

Clinical Signs of Envenomation

1026

Patient Evaluation and Stabilization

1026

Antivenoms

1027

Additional Therapies

1028

References

1029

142 Elapid Snake Envenomation: North American Coral Snakes and Australian Elapids (Tiger Snakes, Brown Snakes, Taipans, Death Adders, and Black Snakes)

1031

Introduction

1031

Elapid Species Identification

1033

North America

1033

Australia

1033

Pathophysiology of Elapid Venoms

1033

Neurotoxins

1033

Procoagulant Toxins

1034

Anticoagulant Toxins

1034

Myotoxins

1034

Hemolytic Toxins

1034

Local-Acting Cytotoxins

1035

Clinical Signs of Envenomation

1035

Preparalytic Signs

1035

Paralysis

1035

Coagulopathy

1035

Rhabdomyolysis

1035

Hemolysis and Anemia

1036

First Aid Advice for Owners

1036

Treatment of Envenomation in Dogs and Cats

1036

Asymptomatic Patients

1036

References

1037

143 Spider and Scorpion Envenomation

1038

Spider Envenomation

1038

Loxoscelism

1038

Lactrodectism

1039

Theraphosidae Spiders

1040

Scorpion Envenomation

1040

Pathophysiology of Envenomation

1040

Clinical Effects of Scorpion Envenomation in People

1040

Treatment of Scorpion Envenomation in People

1041

Scorpion Envenomation in Dogs and Cats

1041

References

1042

144 Bufo Toad Toxicosis

1043

Introduction

1043

Incidence

1044

Signalment

1044

Clinical Signs of Envenomation

1044

Diagnosis

1045

Treatment and Monitoring

1045

Prognosis

1046

Acknowledgments

1046

References

1046

145 Hymenoptera Envenomation

1047

Apoidea

1047

Vespoidea

1047

Formicidea

1047

Venom

1048

Lethal Dose

1048

Clinical Manifestations of Envenomation

1048

Immune-Mediated Response

1048

Systemic Toxic Reactions

1049

Diagnosis

1049

Treatment

1049

Treatment of Systemic Anaphylaxis

1049

Treatment of Toxic and Delayed Reactions

1051

References

1051

146 Hypersensitivity and Anaphylaxis

1053

Incidence and Definitions

1053

Classification and Pathophysiology of Hypersensitivity Reactions and Anaphylaxis

1053

Etiologies and Clinical Manifestations

1054

Diagnosis

1055

Treatment

1056

Antihistamines

1056

Glucocorticoids

1056

Epinephrine

1056

Bronchodilators

1057

Intravenous Fluids and Other Ancillary Treatments

1057

Prognosis

1057

References

1057

147 Canine Heat Stroke

1059

Pathophysiology

1059

Risk Factors for Developing Heat Stroke

1059

Clinical Signs and Diagnosis

1060

Hematological Disorders and Biochemical Abnormalities

1060

Coagulation Disorders and Disseminated Intravascular Coagulation

1061

Other Complications: Acute Kidney Injury, Central Nervous System Dysfunction, ARDS, Cardiac Arrhythmias, and Gastrointestinal Bacterial Translocation

1062

Acute Kidney Injury

1062

Central Nervous System Dysfunction

1062

Acute Respiratory Distress Syndrome

1062

Cardiac Arrhythmias

1062

Gastrointestinal Bacterial Translocation

1062

Treatment Options

1064

Monitoring

1065

Prognosis

1065

Conclusion

1065

References

1065

148 Cold Exposure

1067

Introduction

1067

Pathophysiology of Effects of Cold Exposure [1–3,6–10]

1067

Management [1–3,7–10]

1069

Frostbite

1071

Pathophysiology [1,2,16,20]

1071

Management

1072

References

1072

149 Electrical and Lightning Injuries

1073

Introduction

1073

Electrical Injury

1073

Mechanisms of Electrical Injury

1073

Predisposition to Electrical Injury

1073

Clinical Findings

1074

Secondary Effects of Electrical Injury

1075

Treatment of Electrical Injury

1076

Prognosis

1076

Lightning Injury

1076

References

1077

Section 4 Trauma and Resuscitation

1080

A. Cardiopulmonary Resuscitation

1082

150 Cardiopulmonary Resuscitation in the Emergency Room

1084

Recognition of Cardiopulmonary Arrest

1084

Airway Assessment

1084

Breathing Assessment

1084

Diagnosis of CPA

1084

Basic Life Support

1084

Chest Compressions

1084

Ventilation

1087

Advanced Life Support

1087

Initiating ALS

1087

Interpreting the ECG

1088

Non-Shockable Arrest Rhythms

1089

Shockable Arrest Rhythms

1089

Prognosis

1090

References

1090

151 Small Animal Cardiopulmonary Resuscitation Initiatives

1091

Strategically Advancing the Field of Veterinary CPR

1091

Evidence-Based Consensus Small Animal CPR Guidelines

1091

Knowledge Gaps

1092

Glossary and Guidelines For Standardized Reporting

1092

CPR Registry

1094

Conclusion

1094

References

1094

B. Circulatory Shock

1096

152 Pathophysiology of Shock

1098

Introduction

1098

Cellular Impact

1098

Systemic Impact

1099

Secondary Systemic Sequelae

1100

Systemic Inflammatory Response

1100

Coagulopathy

1100

Mitochondrial Dysfunction

1101

Microcirculatory Dysfunction

1101

Multiple Organ Dysfunction Syndrome

1101

Conclusion

1101

References

1102

153 Hypovolemic Shock

1103

Pathophysiology of Hypovolemic Shock

1103

Decompensation

1104

Diagnosis of Hypovolemic Shock

1104

Physical Examination

1104

Blood Pressure

1105

Electrocardiogram

1105

Laboratory Tests

1105

Diagnostic Imaging

1106

Response to Treatment

1106

Emerging Diagnostic Techniques

1106

Treatment of Hypovolemic Shock

1107

Resuscitation Endpoints

1107

Complications of Hypovolemic Shock

1107

References

1108

154 Cardiogenic Shock

1110

Introduction

1110

Pathophysiology (see Chapter 152)

1110

Incidence and Etiology

1111

Diagnosis

1112

Physical Examination

1112

Electrocardiogram (ECG)

1113

Thoracic Radiography

1113

Laboratory Exam findings, Lactate, Biomarkers, and Arterial Blood Pressure

1113

Echocardiography

1113

Sublingual Microcirculation

1113

Treatment and Monitoring

1113

Conclusion

1115

References

1115

155 Additional Mechanisms of Shock

1117

Introduction

1117

Distributive Shock

1118

SIRS and Sepsis

1118

Anaphylaxis

1118

Hypoadrenocorticism

1118

Neurogenic Shock

1119

Obstructive Shock

1119

Cardiac Tamponade

1119

Pleural Space Disease

1119

Pulmonary Thromboembolism (see Chapters 42 and 62)

1119

Gastric Dilation-Volvulus

1119

Non-Circulatory Shock

1120

Decreased Oxygen Content

1120

Metabolic Aspects

1120

References

1120

156 Lactate Monitoring

1122

Introduction

1122

Lactate Physiology

1122

Causes of Hyperlactatemia

1122

Type 1 Hyperlactatemia without Acidosis

1122

Type 2A Lactic Acidosis

1123

Type 2B Lactic Acidosis

1123

Lactate Measurement

1123

Sample Handling

1124

Patient Selection

1124

Normal Lactate Concentration

1125

Assessment of Hyperlactatemia

1125

Prognostic Implications

1125

Lactate Measurement in Other Body Fluids

1126

References

1126

157 Emerging Monitoring Techniques

1128

Introduction

1128

Venous Oxygen Monitoring

1128

Peripheral Hemodynamic Parameters

1129

Temperature Gradient Monitoring

1129

Sublingual Capnometry

1131

Hemodynamic Component of Pulse Oximetry

1131

Plethysmogram Monitoring (Delta Ppleth)

1131

References

1133

158 Ischemia-Reperfusion Injury

1136

Pathophysiology

1136

Disorders Associated with Ischemia-Reperfusion Injury

1137

Identification of Ischemia-Reperfusion Injury

1139

Management of Ischemia-Reperfusion Injury

1139

Lidocaine

1140

N-Acetylcysteine

1140

Ischemic Preconditioning

1140

Deferoxamine

1140

Allopurinol

1140

Cyclosporine

1140

Remifentanil

1141

Conclusions and Clinical Recommendations

1141

References

1141

159 Systemic Inflammatory Response Syndrome, Sepsis, and Multiple Organ Dysfunction Syndrome

1147

Introduction

1147

Definitions

1147

Pathophysiology

1149

Diagnostic Approach to SIRS and Sepsis

1151

Treatment Approach to SIRS and Sepsis

1152

Treating Shock

1152

Treating Cardiovascular Dysfunction

1152

Antimicrobial Therapy (see Chapter 200)

1153

Source Control

1153

Supportive Care and Managing Organ Dysfunctions

1153

Prognosis for SIRS, Sepsis, and MODS

1153

References

1153

C. Trauma

1156

160 Trauma Overview

1158

Introduction

1158

Overview of the Pathophysiology of Trauma

1158

Epidemiology of Small Animal Trauma

1159

Trauma Scoring Systems

1160

General Approach to the Polytrauma Patient

1160

Considerations for Intravenous Fluid Resuscitation in Trauma

1163

References

1165

161 Trauma Center Registry

1169

Veterinary Trauma Initiative

1169

Trauma Registries: History and Purpose

1169

Trauma Registry: The Future

1169

Acknowledgments

1170

References

1170

162 High-Rise Syndrome

1171

Definition and Pathophysiology

1171

Clinical Signs

1171

Diagnostics

1173

Treatment

1174

Prognosis

1175

References

1176

163 Trauma-Associated Coagulopathy

1177

Introduction

1177

Pathogenesis

1177

Resuscitation-Associated Coagulopathy

1177

Acute Coagulopathy of Trauma-Shock

1178

Trauma-Associated Coagulopathy in Dogs

1180

Hemostatic Testing for Trauma

1181

Conclusion

1181

References

1182

164 Metabolic Consequences of Trauma

1185

Introduction

1185

Sympathoadrenal Activation

1185

Neuroendocrine Activation

1185

Hyperglycemia

1185

Hyperlactatemia

1186

Acid–Base Disorders

1186

Body Temperature

1186

Gastrointestinal Injury

1187

Systemic Inflammation

1187

Activation of the Coagulation Cascade

1187

Conclusion

1188

References

1188

165 Traumatic Orthopedic Emergencies

1189

General Considerations for the Trauma Patient

1189

Fractures

1189

Closed Fractures

1189

Open Fractures

1190

Decision Making for Fracture Repair

1190

Traumatic Joint Injuries

1191

Penetrating Injuries

1191

Traumatic Joint Luxation

1191

Miscellaneous Joint Injury

1192

Skull and Maxillofacial Trauma

1192

References

1194

166 Wound Management Principles

1196

Introduction

1196

Phases of Wound Healing

1196

Inflammation and Debridement Phase

1196

Repair (Proliferative) Phase

1197

Maturation Phase

1198

Wound Closure

1198

Management of Acute Traumatic Wounds and Deciding When and How to Close Them

1198

Initial Wound Care

1199

Deciding on Wound Closure

1200

“Freshening Wound Edges”

1202

Managing Wound Drainage

1202

Antibiotic Therapy in Wound Management

1203

Acute Wounds

1203

Infected Wounds

1203

References

1204

Section 5 Fluid and Blood Product Therapy

1206

167 Crystalloid Fluid Therapy

1208

Introduction

1208

Physiology of Fluid Distribution

1208

Patient Assessment

1208

Types of Crystalloids

1209

Crystalloid Fluids in Resuscitation

1211

Which Crystalloid Should We Use?

1211

How Much Fluid?

1211

Crystalloid Fluids for Rehydration and Maintenance

1212

Complications of Crystalloid Fluid Therapy

1212

References

1212

168 Colloid Fluid Therapy

1214

Introduction

1214

Colloid Osmotic Pressure

1214

Colloid Osmometry

1214

Types of Colloid Solutions

1215

Natural Colloids

1215

Synthetic Colloids

1216

Conclusion

1218

References

1218

169 Crystalloids Versus Colloids

1220

Introduction

1220

Suitability

1220

Fluid Prescription: Crystalloids (see Chapter 167)

1221

Indications

1221

Composition and Selection

1221

Adverse Effects

1222

Fluid Prescription: Colloids (see Chapter 168)

1223

Composition and Selection

1223

Natural Colloids

1223

Synthetic Colloids: Hydroxyethyl Starches

1224

Summary

1226

Fluids: Strategies, Dosages, and Endpoints

1226

References

1228

170 Management of Hemorrhagic Shock

1232

Signalment/History

1232

Physical Examination

1232

Point-of-Care Diagnostics

1233

Laboratory Testing

1233

Emergency Database

1233

Coagulation Assessment (see Chapters 69 and 70)

1233

Radiography and Ultrasound

1233

Treatment

1234

Limiting External Blood Loss

1234

Fluid Resuscitation

1234

Transfusion of Blood Products

1236

Alternatives to Blood Products

1236

Limiting Internal Hemorrhage

1237

Additional Therapy for Specific Conditions

1238

References

1240

Supplemental Reading

1242

171 Management of Dehydration

1243

Introduction

1243

Definition of Dehydration

1243

Estimating Dehydration

1243

Total Body Water

1244

Mechanism of Thirst

1245

Rehydration

1245

Conclusion

1247

References

1247

172 Maintenance Fluid Therapy

1249

Introduction

1249

Estimation of a Patient’s “Maintenance” Fluid Requirement

1249

Composition of a Maintenance Fluid

1250

Use of Maintenance Fluids

1250

Conclusion

1251

References

1251

173 Potassium Supplementation

1253

Introduction

1253

Potassium Physiology

1253

Causes of Hypokalemia

1253

Clinical Signs of Hypokalemia

1254

Potassium Supplementation

1254

Diabetic Ketoacidosis (see Chapter 113)

1255

References

1256

174 Administration of Sodium Bicarbonate

1257

Introduction

1257

Metabolic Acidosis (see Chapter 107)

1258

Is Acidosis Harmful?

1258

Uremic Acidosis

1258

Diabetic Ketoacidosis (see Chapter 113)

1258

Lactic Acidosis (see Chapter 156)

1259

Cardiopulmonary Cerebral Resuscitation (see Chapter 150)

1259

Hyperkalemia (see Chapter 109)

1260

Dosage and Administration

1260

References

1261

175 Continuous-Rate Infusion

1264

Preparing Drug Solutions for Infusions

1264

Fluid Bag Delivery

1264

Drug Infusions Using a Burette

1265

Preparation of Drug Infusions for Bag/Burette

1265

Labeling the Drug Infusion

1265

Standardized Concentration Infusions

1266

Drug Infusions Using a Syringe Pump

1267

Acknowledgment

1267

176 Transfusion of Red Blood Cells and Plasma

1268

Transfusion Therapy

1268

Donor and Recipient Screening

1268

Cross-Matching

1269

Blood Product Administration

1269

Transfusion Reactions

1270

References

1272

177 Massive Transfusion

1273

Introduction

1273

Common Conditions Requiring Massive Transfusion

1273

Diagnosis/Prediction

1273

Pre-Resuscitation Complications/Acute Traumatic Coagulopathy

1274

Treatment

1274

Complications

1275

Electrolyte Abnormalities

1275

Hypothermia (see Chapter 148)

1276

Acid–Base Disorders (see Chapter 107)

1276

Transfusion Reactions (see Chapter 176)

1276

Prognosis

1276

References

1276

Section 6 Emergency Room Procedures

1278

178 Vascular Access

1280

Introduction

1280

Venous Access

1280

Considerations for Venous Access

1280

Approaches and Techniques for Venous Access

1281

Locations for Venous Access

1283

Intraosseous Access

1284

Considerations for Intraosseous Access

1284

Approaches and Techniques for Intraosseous Access

1284

Arterial Access

1285

References

1285

179 Intraosseous Catheters

1286

Introduction

1286

Physiology

1286

Indications

1286

Contraindications

1287

Medications

1287

Methods

1287

Possible Complications

1288

Intraosseous Catheter Care

1288

References

1288

180 Airway Management

1290

Introduction

1290

Healthy Dog or Cat

1290

Upper Airway Obstruction (see Chapters 28 and 30–32)

1290

Difficult Intubation

1291

Tracheostomy

1292

Management of the Tracheostomy Tube

1292

Pharmacological Therapy

1292

References

1293

181 Oxygen Therapy

1294

Introduction

1294

Non-Invasive Oxygen Therapy

1294

Flow-By Oxygen

1294

Face Mask

1295

Oxygen Hood

1295

Nasal Oxygen

1295

Oxygen Cage

1296

Advanced Oxygen Delivery Methods

1296

Transtracheal Oxygen Administration

1296

High-Flow Nasal Cannula

1296

Invasive Oxygen Delivery Methods

1297

Positive Pressure Ventilation

1297

Hyperbaric Oxygen

1297

Monitoring Response to Oxygen Therapy

1297

Oxygen Toxicity

1298

Conclusion

1298

References

1299

182 Sonography in the Emergency Room

1300

Terminology

1300

Abdominal Focused Assessment of Sonography for Trauma (FAST)

1300

Target-Organ Approach

1300

Abdominal Fluid Scoring System

1300

Blunt Versus Penetrating Trauma

1303

Triage or Non-Trauma Subsets: Collapsed, Weak, Hypotensive

1303

Thoracic FAST

1303

Thoracic FAST PCS and DH Views

1303

FAST DH View and CVC for Estimating Volume Status

1306

tFAST Basic Echo Views

1307

tFAST CTS Views

1307

Vet BLUE

1307

Assumptions, Strengths, and Weaknesses of Lung Ultrasound

1307

Global FAST

1308

Global FAST for Patient Monitoring

1308

Global FAST for CPR and Advanced Life Support

1309

References

1309

183 Thoracocentesis

1312

Introduction

1312

Indications

1312

Contraindications

1312

Preparation and Considerations

1312

Procedure

1313

Identify Anatomical Landmarks

1314

Complications

1314

Postprocedure Monitoring

1314

References

1315

184 Thoracostomy Tube Placement

1316

Indications for Thoracostomy Tubes

1316

Pneumothorax

1316

Pleural Effusion (see Chapter 45)

1316

Preparation for Placement

1317

Tube Types

1317

Tube Placement Techniques

1317

Trocar Tubes

1317

Wire-Guided Tube

1317

Red Rubber Catheter

1317

Thoracostomy Tube Maintenance and Care

1318

Complications

1318

References

1318

185 Pericardiocentesis

1319

Etiology and Indications for Pericardiocentesis

1319

Contraindications

1320

Sedation (see Chapter 192)

1320

Equipment

1320

Procedure

1320

Positioning

1320

Procedural Monitoring

1320

Technique

1321

Samples to Obtain and Submit

1321

Postprocedure Monitoring

1321

Complications

1322

Pearls of Wisdom

1322

References

1322

186 Abdominocentesis

1323

Introduction

1323

Indications

1323

Technique

1323

Focused Assessment with Sonography for Trauma (see Chapter 182)

1323

Preparation of the Patient

1324

Closed-Needle Abdominocentesis

1324

Open-Needle Abdominocentesis

1324

Four-Quadrant Abdominocentesis

1324

Alternative Techniques for Abdominocentesis

1324

Diagnostic Peritoneal Lavage

1325

Abdominal Fluid Analysis

1325

Paracentesis Sample

1325

Cytological Analysis

1325

Diagnostic Peritoneal Lavage Samples

1326

Conclusion

1326

References

1326

187 Urethral Catheterization (Including Urohydropulsion)

1327

Introduction

1327

Indications for Urethral Catheterization

1327

Risks of Urethral Catheterization

1328

Catheter Considerations

1328

Size

1328

Materials

1328

Foley Catheters

1328

Placement Technique

1329

Universal

1329

Male Dogs

1329

Female Dogs

1329

Male Cats (see Chapter 98)

1330

Female Cats

1330

Retrograde Urohydropropulsion

1330

Indwelling Catheter Care

1330

References

1331

188 Mechanical Ventilation in the Emergency Room

1333

Introduction

1333

Supplies Required

1333

Personnel

1333

Transport

1333

Owner Communication

1334

Respiratory Distress (Hypoxemia)

1334

Intoxications/Envenomation

1334

Post Cardiopulmonary Resuscitation

1334

Tetraparesis

1334

Ventilation

1335

Conclusion

1335

References

1335

189 Damage Control Surgery

1336

Introduction

1336

Damage Control Surgery Stage 1: Initial Laparotomy

1336

Damage Control Surgery Stage 2: ICU Resuscitation

1338

Damage Control Surgery Stage 3: Definitive Reconstruction

1338

References

1339

Section 7 Anesthesia and Analgesia for the Emergency Room Patient

1340

190 Anesthesia and Analgesia in the Emergency Room: An Overview

1342

Introduction

1342

Origins and Sequelae of Pain

1342

General Approach to the Painful Patient

1343

Treating the Painful Emergent Patient

1343

Analgesic Agents and Tranquilizers (Figure 190.1)

1343

Induction Agents (see Figure 190.1)

1345

Inhalant Anesthetics (see Figure 190.1)

1346

Conclusion

1346

References

1346

191 Anesthetic Concerns and Protocols for Common Conditions

1348

Introduction

1348

Dystocia/Cesarean Section (see Chapter 118)

1348

Anesthetic Concerns

1348

Protocols

1348

Enucleation/Proptosis

1351

Anesthetic Concerns

1351

Protocols

1351

Foreign Body (Esophageal, Gastric, Intestinal)

1351

Anesthetic Concerns

1352

Protocols

1352

Gastric Dilation-Volvulus (see Chapter 82)

1352

Anesthetic Concerns

1352

Protocols

1352

Hemoabdomen (see Chapter 84)

1353

Anesthetic Concerns

1353

Protocols

1353

Major Wounds (see Chapter 166)

1353

Anesthetic Concerns

1353

Protocols

1353

Pacemaker

1354

Anesthetic Concerns

1354

Protocols

1354

Urethral Obstruction (Canine)

1354

Anesthetic Concerns

1354

Protocols

1355

References

1355

192 Sedation for the Emergency Room Patient

1356

Introduction

1356

Healthy Dog/Cat Emergencies

1356

Dog: Fast, Non-Painful Procedure (Radiographs, Blood Draws, Small Laceration Repair)

1356

Cat: Fast, Non-Painful Procedure (Fractious Cat Exam, Radiographs, Blood Draws)

1356

Healthy Dog: Painful Procedure (e.g. Aural Hematoma, Laceration Repair, Fracture Stabilization, Closed Hip Reduction)

1356

Healthy Cat: Painful Procedure (Laceration Repair, Fracture Stabilization, Closed Hip Reduction)

1357

Rapid Sedation For Upper Airway Obstruction/Respiratory Compromise

1357

Sedation Protocols for Brachycephalic Dogs

1357

Geriatric, Debilitated, or Hemodynamically Unstable Cat or Dog Emergencies

1357

Sedation Agents

1357

Opioids

1357

Alpha-2 Agonists

1358

Acepromazine

1358

Benzodiazepines

1358

Induction Agents Used for Sedation

1359

Propofol

1359

Alfaxalone

1359

Ketamine

1359

References

1359

193 Pain Management in Critical Patients

1362

Pain in the Emergency Patient: Concerns and Goals

1362

How Much Pain and How to Approach It

1362

Drug Interactions

1362

Dose Titration, Timing, and Duration

1363

Breakthrough and Unexpected Pain

1363

Pharmacological Methods for Treating Acute Pain

1363

Opioids

1363

NSAIDs

1364

Local Anesthetics

1364

Ketamine

1364

Dexmedetomidine

1364

Gabapentin

1365

Cryotherapy

1365

References

1365

194 Opioids

1367

Introduction

1367

Mechanism of Action

1367

Duration of Action and Administration Techniques

1368

Intravenous and Epidural Administration Techniques

1368

Alternative Routes of Administration

1369

Advantages and Side-Effects

1369

Respiratory Effects

1369

Antitussive Effects

1370

Effects on Body Temperature

1370

Opioid-Induced Hyperalgesia (OIH)

1370

Urine Retention

1370

Other Effects

1370

Patient Management Recommendations

1371

References

1371

195 Alpha-2 Adrenergic Agonists

1372

Introduction

1372

References

1374

196 Non-Steroidal Anti-Inflammatory Drugs

1375

Introduction

1375

Mechanisms of Action

1375

Pharmacokinetics

1376

Adverse Effects

1376

Hemostatic Function

1376

Gastrointestinal Effects

1376

Renal Effects

1376

Hepatic Effects

1377

Drug–Drug Interactions

1377

Clinical Usage

1377

References

1378

197 Regional Anesthesia Techniques

1380

Introduction

1380

Selected Regional Anesthetic Techniques

1380

Intercostal Nerve Blocks

1380

Interpleural Block

1380

Epidural Anesthesia

1382

Potential Complications

1383

Systemic Toxicity

1383

Nerve Injury

1383

Infection

1384

References

1384

198 Go Home Analgesics

1386

Pain Assessment

1386

Pathophysiology of Pain

1386

Go Home Analgesics

1387

Opioids

1387

Non-Steroidal Anti-Inflammatory Drugs

1387

Grapiprant

1389

Adjunctive or Alternative Analgesics

1389

Tramadol

1389

Amantadine

1389

Gabapentin

1389

Tricyclic Antidepressants

1390

Lidocaine Patches

1390

References

1390

199 Approach to the Aggressive or Fearful Emergency Room Patient

1393

Introduction

1393

Patient Fear and Aggression

1393

Recognizing Fear and Aggression in Dogs and Cats

1393

Techniques for Patient Handling and Physical Restraint

1394

Client Communication

1394

Approaching the Patient

1394

Muzzles

1394

Other Manual Restraint Tools

1395

Pharmacologic Restraint of the Aggressive or Fearful Patient

1395

Delivery of Pharmacological Agents for Restraint

1395

Pharmacological Agents for Use in Aggressive Animals

1395

References

1398

Section 8 Unique Emergency Medicine Topics

1400

200 Antimicrobial Therapy in the Emergency Patient

1402

Introduction

1402

General Considerations for Antimicrobial Selection

1402

Approach to Antimicrobial Selection for Patients with Sepsis

1403

Obtaining a Culture

1403

Timing of Antimicrobial Administration

1404

Empiric Antimicrobial Selection (Escalation Versus De-Escalation Therapy)

1404

Pharmacokinetic and Pharmacodynamic Considerations

1405

Duration of Antimicrobial Administration

1406

Source Control

1406

Conclusion

1406

References

1406

201 Disaster Medicine

1409

What is a Disaster?

1409

The Human–Animal Bond During a Disaster

1409

Organizational Structure

1410

Veterinary Disaster Response Programs

1411

Phases of Disaster Management

1411

Mitigation

1411

Preparedness

1411

Response

1412

Recovery

1413

Conclusion

1413

References

1413

202 Working Dogs in the Emergency Room

1415

Occupations

1415

Police/Patrol/Military

1415

Odor Detection

1415

Assistance/Service

1415

Occupational Hazards

1416

Common Conditions

1416

Common Systems Affected

1417

Client Education

1418

References

1419

203 Approach to Unowned and Shelter/Rescue Animals in the Emergency Room

1420

Introduction

1420

References

1422

204 Euthanasia Considerations

1423

Introduction

1423

Emotional Aspects of Euthanasia in the Emergency Setting

1423

Rapport

1423

Goals of Care Discussions in the Emergency Setting

1423

Beliefs Regarding Aid in Dying

1423

Technical Aspects of Euthanasia in the Emergency Setting

1425

Procedural Considerations: Pharmacology and Technique

1425

Procedural Considerations: Treatment Area and Patient Preparation

1425

Procedural Considerations: Client Visiting with Deceased Patients

1427

Current Concepts in Veterinary End-of-Life Care

1427

Veterinary–Social Work Partnerships

1427

Veterinary Hospice and Palliative Care

1427

Client Request for Home Death

1427

Conclusion

1427

References

1428

205 Emergency Room Design and Staffing Models

1430

Introduction

1430

General Design Concepts

1430

Goals

1430

Limitations

1430

Practical Design

1431

Entrance

1431

Reception

1431

Waiting Room

1431

Exam Rooms

1431

Visitation, Consulting, and Grieving Rooms

1432

Emergency Room

1432

Other Hospital Space

1433

Nurses’ Workstation

1434

Doctors’ Workstation

1434

Intensive Care

1434

Radiology

1434

Laboratory

1434

Care Co-ordinator Workstation

1434

Surgery

1434

Isolation

1434

Advanced Imaging (CT and MRI)

1434

Other Design Considerations for the Emergency Room

1434

Flooring

1434

Lighting

1435

Plumbing

1435

Heating, Ventilation, and Cooling

1435

Electrical System

1435

Security

1435

Cart Systems

1435

Medical Gases

1436

Cages and Runs

1436

Design Summary

1436

Staffing the Emergency Room

1436

206 Conflict in the Emergency Room

1439

Introduction

1439

Interpersonal Conflict

1439

Enhancing Constructive Conflict

1441

Conclusion

1443

References

1443

207 Maximizing Communication

1444

Core Communication Skills

1444

Open-Ended Questions

1444

Reflective Listening

1444

Empathy

1445

Non-Verbal Aspects

1445

Breaking the News/Presenting the Diagnosis

1445

Offering Options

1446

Specific Pointers

1446

Conclusion

1446

References

1446

208 Basics of Clinical Study Design

1448

Introduction

1448

The Research Question

1448

Choosing the Appropriate Subjects

1448

Planning and Recording the Measurements

1449

Choosing the Study Design

1449

Case Report

1449

Case Series

1450

Analysis of Secular Trends

1450

Case Control Study

1450

Cohort Study

1450

Experimental Study or Randomized Control Trial

1450

Retrospective Versus Prospective Studies

1450

Analysis

1450

Presenting the Results

1451

Further Reading

1451

209 Designing and Participating in Clinical Trials

1452

Clinical Trial Design

1452

Controlled Clinical Trial Design

1452

Defining the Study Population

1452

Defining the Control Group

1452

Assignment to Intervention Versus Control Groups

1452

Blinding and Outcome Assessment

1454

Placebo Effects

1454

Sample Size Considerations

1454

Statistical Analysis

1454

Clinical Trial Implementation

1455

Recruitment

1455

Data Collection

1456

Good Clinical Practice

1456

References

1456

Index

1457

EULA

1513